Oncology Business Review

Oncology Business Review (OBR) is a leading provider of news, information, and data-driven insights for the oncology community. The company delivers specialized content through digital platforms, including daily news summaries, original feature articles, and in-depth market analysis. Its primary audience includes oncologists, practice administrators, and pharmaceutical executives who require timely information on clinical developments, drug approvals, and healthcare policy. OBR's portfolio of products helps stakeholders navigate the complex business and clinical landscape of cancer care. In 2017, the company was acquired by MJH Life Sciences, integrating its expertise into a larger network of healthcare media and education services.